A. Ciurea

Type de document

Articles (6)

Co-auteur

Date

Source

Mot-clé

Swiss (6) Patients (6) Patients (6) maladie (5) Treatment (5) cohorte (5) maladie (5) thérapie (4) nécrose (4) adulte (4) Inhibitors (4) Therapeutics (4) Necrosis (4) Human beings (4) Quality (4) Necrosis (4) adulte (4) puits (3) société (humaine) (3) gestion (3) Ci (Chinese poetry) (3) Management (3) Older people (3) Management (3) norme (2) comparaison (2) Comparison (2) Methods (2) Tumor necrosis factor (2) Spondylitis (2)

Documents écrit par A. Ciurea (6) | parle de A. Ciurea (0)

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.
M. Hebeisen et al. (2019)
The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.
A. Hiller et al. (2019)
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.
C. Molnar et al.
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
R. Micheroli et al. (19 juil. 2017)
State of Emergency Medicine in Switzerland: a national profile of emergency departments in 2006
B. Sanchez et al. (2013)
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
A. Finckh et al. (2010)